［1］ Wang XS.Look from ESMO consensus liver metastases of colorectal cancer treatment strategies［J］.Chin J Colorectal Dis（Electronic Edition）,2014,1:9-11.［王锡山.从 ESMO 共识看结直肠癌肝转移的治疗策略［J］.中华结直肠疾病电子杂志,2014,1:9-11.］
［2］Kassahun WT.Unresolved issues and controversies surrounding the management of colorectal cancer liver metastasis［J］.World J Surg Oncol,2015,13:61.
［3］Qin XJ,Wang C,Yang Q.Advances intreatmentof colorectal cancerliver metastasis［J］.Modern Oncology,2015,23(14):2069-2071.［秦小金,王成,杨琦.结直肠癌肝转移的治疗进展［J］.现代肿瘤医学,2015,23(14):2069-2071.］
［4］Raluca BA,Cimpean AM,Cioca A,et al.Endothelial cell proliferation and vascular endothelial growth factor expression in primary colorectal cancer and corresponding liver metastases［J］.Asian Pac J Cancer Prev,2015,16(11):4549-4553.
［5］Tacconi C,Correale C,Gandelli A,et al.Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion［J］.Gastroenterology,2015,148(7):1438-1451.
［6］Yun JA,Park Y,Huh JW,et al.Risk factors for the requirement of surgical or endoscopic interventions during chemotherapy in patients with uncomplicated colorectal cancer and unresectable synchronous metastases［J］.J Surg Oncol,2014,110(7):839-844.
［7］Hashimoto T,Itabashi M,Ogawa S,et al.Importance of the postoperative carcinoembryonic antigen level during follow-up after curative resection in patients with liver metastatic colorectal carcinoma［J］.Hepatogastroenterology,2014,61(132):989-993.
［8］Bakalakos EA,Burak WE Jr,Young DC,et al.Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases［J］?Am J Surg,1999,177(1):2-6.
［9］Zimmer R,Thomas P.Mutations in the carcinoembryonic antigen gene in colorectal cancer patients:implications on liver metastasis［J］.Cancer Res,2001,61(7):2822-2826.
［10］Zhang S,Wan D,Pan Z,et al.Multiple factors analysis on liver metastasis from colorectal cancer［J］.Chin Cancer J,2002,24(4):367-369.
［11］Augestad KM,Bakaki PM,Rose J,et al.Metastatic spread pattern after curative colorectal cancer surgery.A retrospective,longitudinal analysis［J］.Cancer Epidemiol,2015,39(5):734-744.
［12］Reinmuth N,Fan F,Liu W,et al.Impact of insulin-like growth factor receptor-I function on angiogenesis,growth,and metastasis of colon cancer［J］.Lab Invest,2002,82(10):1377-1389.
［13］Sharma A,Ng H,Kumar A,et al.Colorectal cancer:Histopathologic differences in tumor characteristics between patients with and without diabetes［J］.Clin Colorectal Cancer,2014,13(1):54-61.
［14］Weber MM,Fottner C,Liu SB,et al.Overexpression of the insulin-like growth factor I receptor in human colon carcinomas［J］.Cancer,2002,95(10):2086-2095.
［15］Chen K,Jiang QT,Ma XY,et al.Associations between genetic polymorphisms of glutathione S-transferase M1 and T1,smoking and susceptibility to colorectal cancer:a case-control study［J］.Chin J Cancer,2004,26(11):645-648.［陈坤,蒋沁婷,马新源,等.谷胱甘肽转移酶T1和M1基因多态性及吸烟与结直肠癌关系的对照研究［J］.中华肿瘤杂志,2004,26(11):645-648.］
［16］Waszkiewicz N,Szajda SD,Waszkiewicz M,et al.The activity of serum beta-galactosidase in colon cancer patients with a history of alcohol and nicotine dependence:preliminary data［J］.Postepy Hig Med Dosw (Online),2013,67:896-900.
［17］Oliveira SC,Santarino IB,Enache TA,et al.Human colon adenocarcinoma HT-29 cell:electrochemistry and nicotine stimulation［J］.Bioelectrochemistry,2013,94:30-38.
［18］Wei PL,Kuo LJ,Huang MT,et al.Nicotine enhances colon cancer cell migration by induction of fibronectin［J］.Ann Surg Oncol,2011,18(6):1782-1790.
［19］Sasaki T,Kuniyasu H,Luo Y,et al.Serum CD10 is associated with liver metastasis in colorectal cancer［J］.J Surg Res,2014,192(2):390-394.
［20］Jing F,Kim HJ,Kim CH,et al.Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases［J］.Int J Oncol,2015,46(4):1582-1588.